| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |